279 related articles for article (PubMed ID: 35762647)
1. Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [
Künze G; Kümpfel R; Rullmann M; Barthel H; Brendel M; Patt M; Sabri O
ACS Chem Neurosci; 2022 Jul; 13(14):2222-2234. PubMed ID: 35762647
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of [
Varlow C; Mathis CA; Vasdev N
Nucl Med Biol; 2024; 130-131():108891. PubMed ID: 38458074
[TBL] [Abstract][Full Text] [Related]
3. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
Murugan NA; Nordberg A; Ågren H
ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
[TBL] [Abstract][Full Text] [Related]
4. Binding characteristics of [
Song M; Beyer L; Kaiser L; Barthel H; van Eimeren T; Marek K; Nitschmann A; Scheifele M; Palleis C; Respondek G; Kern M; Biechele G; Hammes J; Bischof G; Barbe M; Onur Ö; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens AW; Mueller A; Roeber S; Herms J; Bötzel K; Danek A; Levin J; Classen J; Höglinger GU; Bartenstein P; Villemagne V; Drzezga A; Seibyl J; Sabri O; Boening G; Ziegler S; Brendel M
J Cereb Blood Flow Metab; 2021 Nov; 41(11):2957-2972. PubMed ID: 34044665
[TBL] [Abstract][Full Text] [Related]
5. Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils.
Li J; Kumar A; Långström B; Nordberg A; Ågren H
ACS Chem Neurosci; 2023 Sep; 14(18):3528-3539. PubMed ID: 37639522
[TBL] [Abstract][Full Text] [Related]
6. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
Yoshida M
Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.
Zhou Y; Li J; Nordberg A; Ågren H
ACS Chem Neurosci; 2021 Sep; 12(18):3487-3496. PubMed ID: 34464084
[TBL] [Abstract][Full Text] [Related]
8. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
Malarte ML; Gillberg PG; Kumar A; Bogdanovic N; Lemoine L; Nordberg A
Mol Psychiatry; 2023 Mar; 28(3):1272-1283. PubMed ID: 36447011
[TBL] [Abstract][Full Text] [Related]
9. A Machine Learning-Based Approach to Discrimination of Tauopathies Using [
Endo H; Tagai K; Ono M; Ikoma Y; Oyama A; Matsuoka K; Kokubo N; Hirata K; Sano Y; Oya M; Matsumoto H; Kurose S; Seki C; Shimizu H; Kakita A; Takahata K; Shinotoh H; Shimada H; Tokuda T; Kawamura K; Zhang MR; Oishi K; Mori S; Takado Y; Higuchi M
Mov Disord; 2022 Nov; 37(11):2236-2246. PubMed ID: 36054492
[TBL] [Abstract][Full Text] [Related]
10. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
11. Novel tau filament fold in corticobasal degeneration.
Zhang W; Tarutani A; Newell KL; Murzin AG; Matsubara T; Falcon B; Vidal R; Garringer HJ; Shi Y; Ikeuchi T; Murayama S; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
Nature; 2020 Apr; 580(7802):283-287. PubMed ID: 32050258
[TBL] [Abstract][Full Text] [Related]
12. The Role of Tau Proteoforms in Health and Disease.
Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
[TBL] [Abstract][Full Text] [Related]
13. Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.
Siddiqua A; Margittai M
J Biol Chem; 2010 Nov; 285(48):37920-6. PubMed ID: 20921227
[TBL] [Abstract][Full Text] [Related]
14. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease.
Kraus A; Saijo E; Metrick MA; Newell K; Sigurdson CJ; Zanusso G; Ghetti B; Caughey B
Acta Neuropathol; 2019 Apr; 137(4):585-598. PubMed ID: 30570675
[TBL] [Abstract][Full Text] [Related]
15. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
[TBL] [Abstract][Full Text] [Related]
16. Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.
Woerman AL; Aoyagi A; Patel S; Kazmi SA; Lobach I; Grinberg LT; McKee AC; Seeley WW; Olson SH; Prusiner SB
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8187-E8196. PubMed ID: 27911827
[TBL] [Abstract][Full Text] [Related]
17. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
Hosokawa M; Masuda-Suzukake M; Shitara H; Shimozawa A; Suzuki G; Kondo H; Nonaka T; Campbell W; Arai T; Hasegawa M
Brain; 2022 Mar; 145(1):349-361. PubMed ID: 34515757
[TBL] [Abstract][Full Text] [Related]
19. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
[TBL] [Abstract][Full Text] [Related]
20. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]